| Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10269), 99-111, 2021 | 5264 | 2021 |
| Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ... The Lancet 396 (10249), 467-478, 2020 | 2750 | 2020 |
| Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial MN Ramasamy, AM Minassian, KJ Ewer, AL Flaxman, PM Folegatti, ... The Lancet 396 (10267), 1979-1993, 2020 | 1651 | 2020 |
| Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10277), 881-891, 2021 | 1325 | 2021 |
| T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial OCVT Group. Nature Medicine, 2020 | 583* | 2020 |
| Whole-genome sequencing of patients with rare diseases in a national health system E Turro, WJ Astle, K Megy, S Gräf, D Greene, O Shamardina, HL Allen, ... Nature 583 (7814), 96-102, 2020 | 393 | 2020 |
| Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses OCVT Group. Nature Medicine, 2020 | 330* | 2020 |
| The Pain in Neuropathy Study (PiNS): a cross-sectional observational study determining the somatosensory phenotype of painful and painless diabetic neuropathy AC Themistocleous, JD Ramirez, PR Shillo, JG Lees, D Selvarajah, ... Pain 157 (5), 1132-1145, 2016 | 298 | 2016 |
| The clinical approach to small fibre neuropathy and painful channelopathy AC Themistocleous, JD Ramirez, J Serra, DLH Bennett Practical neurology 14 (6), 368-379, 2014 | 193 | 2014 |
| Stratifying patients with peripheral neuropathic pain based on sensory profiles: algorithm and sample size recommendations J Vollert, C Maier, N Attal, DLH Bennett, D Bouhassira, EK Enax-Krumova, ... Pain 158 (8), 1446-1455, 2017 | 185 | 2017 |
| Germline selection shapes human mitochondrial DNA diversity. GPRDP 100, ... Science 364 (6442), eaau6520, 2019 | 182 | 2019 |
| Transcriptional regulator PRDM12 is essential for human pain perception YC Chen, M Auer-Grumbach, S Matsukawa, M Zitzelsberger, ... Nature genetics 47 (7), 803-808, 2015 | 174 | 2015 |
| Defining the functional role of NaV1. 7 in human nociception LA McDermott, GA Weir, AC Themistocleous, AR Segerdahl, I Blesneac, ... Neuron 101 (5), 905-919. e8, 2019 | 168 | 2019 |
| Whole-genome sequencing of a sporadic primary immunodeficiency cohort OS Thaventhiran, J.E.D., Lango Allen, H., Burren Nature, 2020 | 165 | 2020 |
| Immune or genetic-mediated disruption of CASPR2 causes pain hypersensitivity due to enhanced primary afferent excitability JM Dawes, GA Weir, SJ Middleton, R Patel, KI Chisholm, P Pettingill, ... Neuron 97 (4), 806-822. e10, 2018 | 149 | 2018 |
| Rare NaV1. 7 variants associated with painful diabetic peripheral neuropathy I Blesneac, AC Themistocleous, C Fratter, LJ Conrad, JD Ramirez, JJ Cox, ... Pain 159 (3), 469-480, 2018 | 140 | 2018 |
| Painful and non-painful diabetic neuropathy, diagnostic challenges and implications for future management TS Jensen, P Karlsson, SS Gylfadottir, ST Andersen, DL Bennett, ... Brain 144 (6), 1632-1645, 2021 | 119 | 2021 |
| Studying human nociceptors: from fundamentals to clinic SJ Middleton, AM Barry, M Comini, Y Li, PR Ray, S Shiers, ... Brain 144 (5), 1312-1335, 2021 | 103 | 2021 |
| A brain-based pain facilitation mechanism contributes to painful diabetic polyneuropathy AR Segerdahl, AC Themistocleous, D Fido, DL Bennett, I Tracey Brain 141 (2), 357-364, 2018 | 95 | 2018 |
| COVID-19 vaccination and Guillain-Barré syndrome: analyses using the National Immunoglobulin Database RYS Keh, S Scanlon, P Datta-Nemdharry, K Donegan, S Cavanagh, ... Brain 146 (2), 739-748, 2023 | 74 | 2023 |
